APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hepatitis A Vaccine

Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.

Two types of HAV vaccines are currently available internationally:

1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).

2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.

Selected research

Market Analysis & Forecast

Global Hepatitis A Vaccine Market Analysis and Forecast 2026-2032

26 December 2025194 pages

Choose your research edition.

Industry ResearchHepatitis A Vaccine Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Hepatitis A Vaccine Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Hepatitis A Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hepatitis A Vaccine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Hepatitis A Vaccine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.

Two types of HAV vaccines are currently available internationally:

1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).

Read the full market overview

2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.

Global Hepatitis A Vaccine key players include GSK, Merck, Sanofi, etc. Global top three manufacturers hold a share over 85%.

Europe is the largest market, with a share over 30%, followed by North America and China, both have a share about 45 percent.

In terms of product, Inactivated Vaccine is the largest segment, with a share about 70%. And in terms of application, the largest application is Government Institution, followed by Private Sector, etc.

This report presents an overview of global market for Hepatitis A Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Hepatitis A Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Hepatitis A Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Hepatitis A Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Hepatitis A Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Hepatitis A Vaccine sales, projected growth trends, production technology, application and end-user industry.

Hepatitis A Vaccine Segment by Company

GSK

Merck

Sanofi

Sinovac

Zhejiang Pukang

Changchun Institute of Biological

KM Biologics

IMBCA

ChangSheng

Convac

Hepatitis A Vaccine Segment by Type

Inactivated Vaccine

Live Attenuated Vaccine

Hepatitis A Vaccine Segment by Application

Government Institution

Private Sector

Other

Hepatitis A Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hepatitis A Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hepatitis A Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hepatitis A Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Hepatitis A Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Hepatitis A Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hepatitis A Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Hepatitis A Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Inactivated Vaccine Major Manufacturers Table 3. Live Attenuated Vaccine Major Manufacturers Table 4. Global Hepatitis A Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Government Institution Major Manufacturers Table 6. Private Sector Major Manufacturers Table 7. Other Major Manufacturers Table 8. Hepatitis A Vaccine Industry Trends Table 9. Hepatitis A Vaccine Industry Drivers Table 10. Hepatitis A Vaccine Industry Opportunities and Challenges Table 11. Hepatitis A Vaccine Industry Restraints Table 12. Global Hepatitis A Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Hepatitis A Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Hepatitis A Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Hepatitis A Vaccine Revenue Market Share by Region (2021-2026) Table 16. Global Hepatitis A Vaccine Revenue Market Share by Region (2027-2032) Table 17. Global Hepatitis A Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Unit) Table 18. Global Hepatitis A Vaccine Sales by Region (2021-2026) & (K Unit) Table 19. Global Hepatitis A Vaccine Sales by Region (2027-2032) & (K Unit) Table 20. Global Hepatitis A Vaccine Sales Market Share by Region (2021-2026) Table 21. Global Hepatitis A Vaccine Sales Market Share by Region (2027-2032) Table 22. Global Hepatitis A Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Hepatitis A Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Hepatitis A Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Hepatitis A Vaccine Sales Market Share by Manufacturers (2021-2026) Table 26. Global Hepatitis A Vaccine Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 27. Global Hepatitis A Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Hepatitis A Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Hepatitis A Vaccine Manufacturers, Product Type & Application Table 30. Global Hepatitis A Vaccine Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Hepatitis A Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Hepatitis A Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Hepatitis A Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Hepatitis A Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Hepatitis A Vaccine Revenue Market Share by Type (2021-2026) Table 37. Global Hepatitis A Vaccine Revenue Market Share by Type (2027-2032) Table 38. Global Hepatitis A Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Unit) Table 39. Global Hepatitis A Vaccine Sales by Type (2021-2026) & (K Unit) Table 40. Global Hepatitis A Vaccine Sales by Type (2027-2032) & (K Unit) Table 41. Global Hepatitis A Vaccine Sales Market Share by Type (2021-2026) Table 42. Global Hepatitis A Vaccine Sales Market Share by Type (2027-2032) Table 43. Global Hepatitis A Vaccine Price by Type (2021-2026) & (USD/Unit) Table 44. Global Hepatitis A Vaccine Price by Type (2027-2032) & (USD/Unit) Table 45. Global Hepatitis A Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Hepatitis A Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Hepatitis A Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Hepatitis A Vaccine Revenue Market Share by Application (2021-2026) Table 49. Global Hepatitis A Vaccine Revenue Market Share by Application (2027-2032) Table 50. Global Hepatitis A Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Unit) Table 51. Global Hepatitis A Vaccine Sales by Application (2021-2026) & (K Unit) Table 52. Global Hepatitis A Vaccine Sales by Application (2027-2032) & (K Unit) Table 53. Global Hepatitis A Vaccine Sales Market Share by Application (2021-2026) Table 54. Global Hepatitis A Vaccine Sales Market Share by Application (2027-2032) Table 55. Global Hepatitis A Vaccine Price by Application (2021-2026) & (USD/Unit) Table 56. Global Hepatitis A Vaccine Price by Application (2027-2032) & (USD/Unit) Table 57. GSK Company Information Table 58. GSK Business Overview Table 59. GSK Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 60. GSK Hepatitis A Vaccine Product Portfolio Table 61. GSK Recent Development Table 62. Merck Company Information Table 63. Merck Business Overview Table 64. Merck Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 65. Merck Hepatitis A Vaccine Product Portfolio Table 66. Merck Recent Development Table 67. Sanofi Company Information Table 68. Sanofi Business Overview Table 69. Sanofi Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 70. Sanofi Hepatitis A Vaccine Product Portfolio Table 71. Sanofi Recent Development Table 72. Sinovac Company Information Table 73. Sinovac Business Overview Table 74. Sinovac Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 75. Sinovac Hepatitis A Vaccine Product Portfolio Table 76. Sinovac Recent Development Table 77. Zhejiang Pukang Company Information Table 78. Zhejiang Pukang Business Overview Table 79. Zhejiang Pukang Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 80. Zhejiang Pukang Hepatitis A Vaccine Product Portfolio Table 81. Zhejiang Pukang Recent Development Table 82. Changchun Institute of Biological Company Information Table 83. Changchun Institute of Biological Business Overview Table 84. Changchun Institute of Biological Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 85. Changchun Institute of Biological Hepatitis A Vaccine Product Portfolio Table 86. Changchun Institute of Biological Recent Development Table 87. KM Biologics Company Information Table 88. KM Biologics Business Overview Table 89. KM Biologics Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 90. KM Biologics Hepatitis A Vaccine Product Portfolio Table 91. KM Biologics Recent Development Table 92. IMBCA Company Information Table 93. IMBCA Business Overview Table 94. IMBCA Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 95. IMBCA Hepatitis A Vaccine Product Portfolio Table 96. IMBCA Recent Development Table 97. ChangSheng Company Information Table 98. ChangSheng Business Overview Table 99. ChangSheng Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 100. ChangSheng Hepatitis A Vaccine Product Portfolio Table 101. ChangSheng Recent Development Table 102. Convac Company Information Table 103. Convac Business Overview Table 104. Convac Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 105. Convac Hepatitis A Vaccine Product Portfolio Table 106. Convac Recent Development Table 107. North America Hepatitis A Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 108. North America Hepatitis A Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 109. North America Hepatitis A Vaccine Sales by Type (2021-2026) & (K Unit) Table 110. North America Hepatitis A Vaccine Sales by Type (2027-2032) & (K Unit) Table 111. North America Hepatitis A Vaccine Sales Price by Type (2021-2026) & (USD/Unit) Table 112. North America Hepatitis A Vaccine Sales Price by Type (2027-2032) & (USD/Unit) Table 113. North America Hepatitis A Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 114. North America Hepatitis A Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 115. North America Hepatitis A Vaccine Sales by Application (2021-2026) & (K Unit) Table 116. North America Hepatitis A Vaccine Sales by Application (2027-2032) & (K Unit) Table 117. North America Hepatitis A Vaccine Sales Price by Application (2021-2026) & (USD/Unit) Table 118. North America Hepatitis A Vaccine Sales Price by Application (2027-2032) & (USD/Unit) Table 119. North America Hepatitis A Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. North America Hepatitis A Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 121. North America Hepatitis A Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 122. North America Hepatitis A Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Unit) Table 123. North America Hepatitis A Vaccine Sales by Country (2021-2026) & (K Unit) Table 124. North America Hepatitis A Vaccine Sales by Country (2027-2032) & (K Unit) Table 125. North America Hepatitis A Vaccine Sales Price by Country (2021-2026) & (USD/Unit) Table 126. North America Hepatitis A Vaccine Sales Price by Country (2027-2032) & (USD/Unit) Table 127. United States Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Table 128. Canada Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Table 129. Mexico Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Table 130. Europe Hepatitis A Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 131. Europe Hepatitis A Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 132. Europe Hepatitis A Vaccine Sales by Type (2021-2026) & (K Unit) Table 133. Europe Hepatitis A Vaccine Sales by Type (2027-2032) & (K Unit) Table 134. Europe Hepatitis A Vaccine Sales Price by Type (2021-2026) & (USD/Unit) Table 135. Europe Hepatitis A Vaccine Sales Price by Type (2027-2032) & (USD/Unit) Table 136. Europe Hepatitis A Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 137. Europe Hepatitis A Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 138. Europe Hepatitis A Vaccine Sales by Application (2021-2026) & (K Unit) Table 139. Europe Hepatitis A Vaccine Sales by Application (2027-2032) & (K Unit) Table 140. Europe Hepatitis A Vaccine Sales Price by Application (2021-2026) & (USD/Unit) Table 141. Europe Hepatitis A Vaccine Sales Price by Application (2027-2032) & (USD/Unit) Table 142. Europe Hepatitis A Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Europe Hepatitis A Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 144. Europe Hepatitis A Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 145. Europe Hepatitis A Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Unit) Table 146. Europe Hepatitis A Vaccine Sales by Country (2021-2026) & (K Unit) Table 147. Europe Hepatitis A Vaccine Sales by Country (2027-2032) & (K Unit) Table 148. Europe Hepatitis A Vaccine Sales Price by Country (2021-2026) & (USD/Unit) Table 149. Europe Hepatitis A Vaccine Sales Price by Country (2027-2032) & (USD/Unit) Table 150. Germany Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Table 151. France Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Table 152. U.K. Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Table 153. Italy Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Table 154. Russia Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Table 155. Spain Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Table 156. Netherlands Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Table 157. Switzerland Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Table 158. Sweden Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Table 159. Poland Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Table 160. China Hepatitis A Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 161. China Hepatitis A Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 162. China Hepatitis A Vaccine Sales by Type (2021-2026) & (K Unit) Table 163. China Hepatitis A Vaccine Sales by Type (2027-2032) & (K Unit) Table 164. China Hepatitis A Vaccine Sales Price by Type (2021-2026) & (USD/Unit) Table 165. China Hepatitis A Vaccine Sales Price by Type (2027-2032) & (USD/Unit) Table 166. China Hepatitis A Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 167. China Hepatitis A Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 168. China Hepatitis A Vaccine Sales by Application (2021-2026) & (K Unit) Table 169. China Hepatitis A Vaccine Sales by Application (2027-2032) & (K Unit) Table 170. China Hepatitis A Vaccine Sales Price by Application (2021-2026) & (USD/Unit) Table 171. China Hepatitis A Vaccine Sales Price by Application (2027-2032) & (USD/Unit) Table 172. Asia Hepatitis A Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 173. Asia Hepatitis A Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 174. Asia Hepatitis A Vaccine Sales by Type (2021-2026) & (K Unit) Table 175. Asia Hepatitis A Vaccine Sales by Type (2027-2032) & (K Unit) Table 176. Asia Hepatitis A Vaccine Sales Price by Type (2021-2026) & (USD/Unit) Table 177. Asia Hepatitis A Vaccine Sales Price by Type (2027-2032) & (USD/Unit) Table 178. Asia Hepatitis A Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 179. Asia Hepatitis A Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 180. Asia Hepatitis A Vaccine Sales by Application (2021-2026) & (K Unit) Table 181. Asia Hepatitis A Vaccine Sales by Application (2027-2032) & (K Unit) Table 182. Asia Hepatitis A Vaccine Sales Price by Application (2021-2026) & (USD/Unit) Table 183. Asia Hepatitis A Vaccine Sales Price by Application (2027-2032) & (USD/Unit) Table 184. Asia Hepatitis A Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. Asia Hepatitis A Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. Asia Hepatitis A Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. Asia Hepatitis A Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Unit) Table 188. Asia Hepatitis A Vaccine Sales by Country (2021-2026) & (K Unit) Table 189. Asia Hepatitis A Vaccine Sales by Country (2027-2032) & (K Unit) Table 190. Asia Hepatitis A Vaccine Sales Price by Country (2021-2026) & (USD/Unit) Table 191. Asia Hepatitis A Vaccine Sales Price by Country (2027-2032) & (USD/Unit) Table 192. Japan Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Table 193. South Korea Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Table 194. India Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Table 195. Australia Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Table 196. Taiwan Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Table 197. Southeast Asia Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Table 198. SAMEA Hepatitis A Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 199. SAMEA Hepatitis A Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 200. SAMEA Hepatitis A Vaccine Sales by Type (2021-2026) & (K Unit) Table 201. SAMEA Hepatitis A Vaccine Sales by Type (2027-2032) & (K Unit) Table 202. SAMEA Hepatitis A Vaccine Sales Price by Type (2021-2026) & (USD/Unit) Table 203. SAMEA Hepatitis A Vaccine Sales Price by Type (2027-2032) & (USD/Unit) Table 204. SAMEA Hepatitis A Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 205. SAMEA Hepatitis A Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 206. SAMEA Hepatitis A Vaccine Sales by Application (2021-2026) & (K Unit) Table 207. SAMEA Hepatitis A Vaccine Sales by Application (2027-2032) & (K Unit) Table 208. SAMEA Hepatitis A Vaccine Sales Price by Application (2021-2026) & (USD/Unit) Table 209. SAMEA Hepatitis A Vaccine Sales Price by Application (2027-2032) & (USD/Unit) Table 210. SAMEA Hepatitis A Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 211. SAMEA Hepatitis A Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 212. SAMEA Hepatitis A Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 213. SAMEA Hepatitis A Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Unit) Table 214. SAMEA Hepatitis A Vaccine Sales by Country (2021-2026) & (K Unit) Table 215. SAMEA Hepatitis A Vaccine Sales by Country (2027-2032) & (K Unit) Table 216. SAMEA Hepatitis A Vaccine Sales Price by Country (2021-2026) & (USD/Unit) Table 217. SAMEA Hepatitis A Vaccine Sales Price by Country (2027-2032) & (USD/Unit) Table 218. Brazil Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Table 219. Argentina Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Table 220. Chile Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Table 221. Colombia Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Table 222. Peru Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Table 223. Saudi Arabia Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Table 224. Israel Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Table 225. UAE Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Table 226. Turkey Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Table 227. Iran Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Table 228. Egypt Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Table 229. Key Raw Materials Table 230. Raw Materials Key Suppliers Table 231. Hepatitis A Vaccine Distributors List Table 232. Hepatitis A Vaccine Customers List Table 233. Research Programs/Design for This Report Table 234. Authors List of This Report Table 235. Secondary Sources Table 236. Primary Sources List of Figures Figure 1. Hepatitis A Vaccine Image Figure 2. Global Hepatitis A Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hepatitis A Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Inactivated Vaccine Image Figure 5. Live Attenuated Vaccine Image Figure 6. Global Hepatitis A Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Hepatitis A Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Government Institution Image Figure 9. Private Sector Image Figure 10. Other Image Figure 11. Global Hepatitis A Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Figure 13. Global Hepatitis A Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Hepatitis A Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Hepatitis A Vaccine Revenue Market Share by Region (2021-2032) Figure 16. Global Hepatitis A Vaccine Sales (2021-2032) & (K Unit) Figure 17. Global Hepatitis A Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Unit) Figure 18. Global Hepatitis A Vaccine Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Hepatitis A Vaccine Sales YoY (2021-2032) & (K Unit) Figure 20. Europe Hepatitis A Vaccine Sales YoY (2021-2032) & (K Unit) Figure 21. China Hepatitis A Vaccine Sales YoY (2021-2032) & (K Unit) Figure 22. Asia (Excluding China) Hepatitis A Vaccine Sales YoY (2021-2032) & (K Unit) Figure 23. South America, Middle East and Africa Hepatitis A Vaccine Sales YoY (2021-2032) & (K Unit) Figure 24. Global Hepatitis A Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Hepatitis A Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Hepatitis A Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Hepatitis A Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Hepatitis A Vaccine Revenue Market Share by Type (2021-2032) Figure 30. Global Hepatitis A Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Unit) Figure 31. Global Hepatitis A Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Hepatitis A Vaccine Sales Market Share by Type (2021-2032) Figure 33. Global Hepatitis A Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Hepatitis A Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Hepatitis A Vaccine Revenue Market Share by Application (2021-2032) Figure 36. Global Hepatitis A Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Unit) Figure 37. Global Hepatitis A Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Hepatitis A Vaccine Sales Market Share by Application (2021-2032) Figure 39. North America Hepatitis A Vaccine Revenue Share by Type (2021-2032) Figure 40. North America Hepatitis A Vaccine Sales Share by Type (2021-2032) Figure 41. North America Hepatitis A Vaccine Revenue Share by Application (2021-2032) Figure 42. North America Hepatitis A Vaccine Sales Share by Application (2021-2032) Figure 43. North America Hepatitis A Vaccine Revenue Share by Country (2021-2032) Figure 44. North America Hepatitis A Vaccine Sales Share by Country (2021-2032) Figure 45. Europe Hepatitis A Vaccine Revenue Share by Type (2021-2032) Figure 46. Europe Hepatitis A Vaccine Sales Share by Type (2021-2032) Figure 47. Europe Hepatitis A Vaccine Revenue Share by Application (2021-2032) Figure 48. Europe Hepatitis A Vaccine Sales Share by Application (2021-2032) Figure 49. Europe Hepatitis A Vaccine Revenue Share by Country (2021-2032) Figure 50. Europe Hepatitis A Vaccine Sales Share by Country (2021-2032) Figure 51. China Hepatitis A Vaccine Revenue Share by Type (2021-2032) Figure 52. China Hepatitis A Vaccine Sales Share by Type (2021-2032) Figure 53. China Hepatitis A Vaccine Revenue Share by Application (2021-2032) Figure 54. China Hepatitis A Vaccine Sales Share by Application (2021-2032) Figure 55. Asia Hepatitis A Vaccine Revenue Share by Type (2021-2032) Figure 56. Asia Hepatitis A Vaccine Sales Share by Type (2021-2032) Figure 57. Asia Hepatitis A Vaccine Revenue Share by Application (2021-2032) Figure 58. Asia Hepatitis A Vaccine Sales Share by Application (2021-2032) Figure 59. Asia Hepatitis A Vaccine Revenue Share by Country (2021-2032) Figure 60. Asia Hepatitis A Vaccine Sales Share by Country (2021-2032) Figure 61. SAMEA Hepatitis A Vaccine Revenue Share by Type (2021-2032) Figure 62. SAMEA Hepatitis A Vaccine Sales Share by Type (2021-2032) Figure 63. SAMEA Hepatitis A Vaccine Revenue Share by Application (2021-2032) Figure 64. SAMEA Hepatitis A Vaccine Sales Share by Application (2021-2032) Figure 65. SAMEA Hepatitis A Vaccine Revenue Share by Country (2021-2032) Figure 66. SAMEA Hepatitis A Vaccine Sales Share by Country (2021-2032) Figure 67. Hepatitis A Vaccine Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Hepatitis A Vaccine Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Inactivated Vaccine
  • Live Attenuated Vaccine
Applications
  • Government Institution
  • Private Sector
  • Other
Companies covered
  • GSK
  • Merck
  • Sanofi
  • Sinovac
  • Zhejiang Pukang
  • Changchun Institute of Biological
  • KM Biologics
  • IMBCA
  • ChangSheng
  • Convac

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Hepatitis A Vaccine Market by Type
  3. 1.2.1 Global Hepatitis A Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Inactivated Vaccine
  5. 1.2.3 Live Attenuated Vaccine
  6. 1.3 Hepatitis A Vaccine Market by Application
  7. 1.3.1 Global Hepatitis A Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Government Institution
  9. 1.3.3 Private Sector
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Hepatitis A Vaccine Market Dynamics
  1. 2.1 Hepatitis A Vaccine Industry Trends
  2. 2.2 Hepatitis A Vaccine Industry Drivers
  3. 2.3 Hepatitis A Vaccine Industry Opportunities and Challenges
  4. 2.4 Hepatitis A Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Hepatitis A Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Hepatitis A Vaccine Revenue by Region
  3. 3.2.1 Global Hepatitis A Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Hepatitis A Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Hepatitis A Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Hepatitis A Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Hepatitis A Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Hepatitis A Vaccine Sales by Region
  9. 3.4.1 Global Hepatitis A Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Hepatitis A Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Hepatitis A Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Hepatitis A Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Hepatitis A Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Hepatitis A Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Hepatitis A Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Hepatitis A Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Hepatitis A Vaccine Sales by Manufacturers
  6. 4.2.1 Global Hepatitis A Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Hepatitis A Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Hepatitis A Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Hepatitis A Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Hepatitis A Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Hepatitis A Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Hepatitis A Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Hepatitis A Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Hepatitis A Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Hepatitis A Vaccine Tier 1, Tier 2, and Tier 3
5 Hepatitis A Vaccine Market by Type
  1. 5.1 Global Hepatitis A Vaccine Revenue by Type
  2. 5.1.1 Global Hepatitis A Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Hepatitis A Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Hepatitis A Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Hepatitis A Vaccine Sales by Type
  6. 5.2.1 Global Hepatitis A Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Hepatitis A Vaccine Sales by Type (2021-2032) & (K Unit)
  8. 5.2.3 Global Hepatitis A Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Hepatitis A Vaccine Price by Type
6 Hepatitis A Vaccine Market by Application
  1. 6.1 Global Hepatitis A Vaccine Revenue by Application
  2. 6.1.1 Global Hepatitis A Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Hepatitis A Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Hepatitis A Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Hepatitis A Vaccine Sales by Application
  6. 6.2.1 Global Hepatitis A Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Hepatitis A Vaccine Sales by Application (2021-2032) & (K Unit)
  8. 6.2.3 Global Hepatitis A Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Hepatitis A Vaccine Price by Application
7 Company Profiles
  1. 7.1 GSK
  2. 7.1.1 GSK Company Information
  3. 7.1.2 GSK Business Overview
  4. 7.1.3 GSK Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 GSK Hepatitis A Vaccine Product Portfolio
  6. 7.1.5 GSK Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck Hepatitis A Vaccine Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 Sanofi
  14. 7.3.1 Sanofi Company Information
  15. 7.3.2 Sanofi Business Overview
  16. 7.3.3 Sanofi Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sanofi Hepatitis A Vaccine Product Portfolio
  18. 7.3.5 Sanofi Recent Developments
  19. 7.4 Sinovac
  20. 7.4.1 Sinovac Company Information
  21. 7.4.2 Sinovac Business Overview
  22. 7.4.3 Sinovac Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Sinovac Hepatitis A Vaccine Product Portfolio
  24. 7.4.5 Sinovac Recent Developments
  25. 7.5 Zhejiang Pukang
  26. 7.5.1 Zhejiang Pukang Company Information
  27. 7.5.2 Zhejiang Pukang Business Overview
  28. 7.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Zhejiang Pukang Hepatitis A Vaccine Product Portfolio
  30. 7.5.5 Zhejiang Pukang Recent Developments
  31. 7.6 Changchun Institute of Biological
  32. 7.6.1 Changchun Institute of Biological Company Information
  33. 7.6.2 Changchun Institute of Biological Business Overview
  34. 7.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Changchun Institute of Biological Hepatitis A Vaccine Product Portfolio
  36. 7.6.5 Changchun Institute of Biological Recent Developments
  37. 7.7 KM Biologics
  38. 7.7.1 KM Biologics Company Information
  39. 7.7.2 KM Biologics Business Overview
  40. 7.7.3 KM Biologics Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 KM Biologics Hepatitis A Vaccine Product Portfolio
  42. 7.7.5 KM Biologics Recent Developments
  43. 7.8 IMBCA
  44. 7.8.1 IMBCA Company Information
  45. 7.8.2 IMBCA Business Overview
  46. 7.8.3 IMBCA Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 IMBCA Hepatitis A Vaccine Product Portfolio
  48. 7.8.5 IMBCA Recent Developments
  49. 7.9 ChangSheng
  50. 7.9.1 ChangSheng Company Information
  51. 7.9.2 ChangSheng Business Overview
  52. 7.9.3 ChangSheng Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 ChangSheng Hepatitis A Vaccine Product Portfolio
  54. 7.9.5 ChangSheng Recent Developments
  55. 7.10 Convac
  56. 7.10.1 Convac Company Information
  57. 7.10.2 Convac Business Overview
  58. 7.10.3 Convac Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Convac Hepatitis A Vaccine Product Portfolio
  60. 7.10.5 Convac Recent Developments
8 North America
  1. 8.1 North America Hepatitis A Vaccine Market Size by Type
  2. 8.1.1 North America Hepatitis A Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Hepatitis A Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Hepatitis A Vaccine Price by Type (2021-2032)
  5. 8.2 North America Hepatitis A Vaccine Market Size by Application
  6. 8.2.1 North America Hepatitis A Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Hepatitis A Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Hepatitis A Vaccine Price by Application (2021-2032)
  9. 8.3 North America Hepatitis A Vaccine Market Size by Country
  10. 8.3.1 North America Hepatitis A Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Hepatitis A Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Hepatitis A Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Hepatitis A Vaccine Market Size by Type
  2. 9.1.1 Europe Hepatitis A Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Hepatitis A Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Hepatitis A Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Hepatitis A Vaccine Market Size by Application
  6. 9.2.1 Europe Hepatitis A Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Hepatitis A Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Hepatitis A Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Hepatitis A Vaccine Market Size by Country
  10. 9.3.1 Europe Hepatitis A Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Hepatitis A Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Hepatitis A Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Hepatitis A Vaccine Market Size by Type
  2. 10.1.1 China Hepatitis A Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Hepatitis A Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Hepatitis A Vaccine Price by Type (2021-2032)
  5. 10.2 China Hepatitis A Vaccine Market Size by Application
  6. 10.2.1 China Hepatitis A Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Hepatitis A Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Hepatitis A Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Hepatitis A Vaccine Market Size by Type
  2. 11.1.1 Asia Hepatitis A Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Hepatitis A Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Hepatitis A Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Hepatitis A Vaccine Market Size by Application
  6. 11.2.1 Asia Hepatitis A Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Hepatitis A Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Hepatitis A Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Hepatitis A Vaccine Market Size by Country
  10. 11.3.1 Asia Hepatitis A Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Hepatitis A Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Hepatitis A Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Hepatitis A Vaccine Market Size by Type
  2. 12.1.1 SAMEA Hepatitis A Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Hepatitis A Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Hepatitis A Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Hepatitis A Vaccine Market Size by Application
  6. 12.2.1 SAMEA Hepatitis A Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Hepatitis A Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Hepatitis A Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Hepatitis A Vaccine Market Size by Country
  10. 12.3.1 SAMEA Hepatitis A Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Hepatitis A Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Hepatitis A Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Hepatitis A Vaccine Value Chain Analysis
  2. 13.1.1 Hepatitis A Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Hepatitis A Vaccine Production Mode & Process
  6. 13.2 Hepatitis A Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Hepatitis A Vaccine Distributors
  9. 13.2.3 Hepatitis A Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst